Pharmafile Logo

#RemoteDetailing

- PMLiVE

The hitchhiker’s guide to the millennial healthcare professional

Originally written in the late 1970s, Douglas Adams’ well-loved sci-fi masterpiece, The Hitchhiker’s Guide To The Galaxy, tells the story of Arthur Dent as he flees Earth shortly before it’s...

IBM Watson sees early-stage ‘breakthrough’ in viral diseases

Produces macromolecule that could one day neutralise deadly infections

- PMLiVE

Glycotope appoints Dr Alfredo Zurlo as chief medical officer

He joins the German clinical-stage immuno-oncology company from Mologen

NewLink

NewLink pancreatic cancer vaccine flunks phase III test

Survival rate slightly lower for patients on vaccine than those in control group

- PMLiVE

Cell Therapy licenses heart failure therapy in Japan

EMA may grant Welsh-based biotech a marketing application in mid-2016

- PMLiVE

Lost for words? Try picturing this… by Mark Spain and Sharon Ombler-Spain

The Two Visual Thinkers' blog about the benefits of recording information visually to engage and educate a variety of audiences.

Say Communications

New talent blooms at Lucid Group

Spring has most definitely sprung at Lucid Group as they welcome three new employees to their team. Laura Cunliffe joins as a Senior Account Manager at Leading Edge and will...

Lucid Group Communications Limited

- PMLiVE

Medical affairs – the time for change is now

The function is uniquely placed to help pharma overcome today’s most pressing healthcare challenges

dengue fever mosquito

Malaria vaccine is first to provide ‘sustained protection’

Latest trial shows immunological response lasts for at least a year

Allergan logo

Allergan on course to file uterine fibroid drug next year

New drug could be safer and more effective than existing treatment

Cromsource expands executive leadership team

Dr Troy McCall, Dr Kerry Dyson, April McCall and Debbie Kent take up new roles

- PMLiVE

Plaudits for Bayer’s website

Ranked number two in Bowen Cragg's annual Index of Online Excellence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links